查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197818

眼科超聲市場 - 增長、趨勢、COVID-19 影響和預測 (2023-28)

Ophthalmic Ultrasound Systems Market - Growth, Trends, and Forecasts (2023-28)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，眼科超聲系統市場預計將以 7% 的複合年增長率增長。

大流行影響了市場，各種研究提供了這種見解。 例如，根據 Parul C Gupta 等人在 2021 年 12 月出版的《印度眼科雜誌》上發表的一項研究，接受調查的診所計劃進行 7,500 次白內障手術，但由於大流行，只有 2,500 次。他說他不能。 數據表明，在 COVID-19 大流行期間，白內障手術顯著減少。 然而，隨著長時間工作導致屏幕時間增加，眼病是全球最常報告的問題之一，導致眼病患病率增加，研究期間的調查可能會提振市場生長。 例如，根據 Jason M. Nagata 等人發表的一項研究，屏幕時間增加會對青少年的身心健康產生負面影響。 因此，預計 COVID-19 的長期影響將對所研究的市場產生有利影響。

全球近視（nearsightedness）、遠視（hyperopia）、散光（distorted vision）和老花眼等光學損傷負擔日益加重，將在研究預測期內推動超聲眼科設備市場的增長。預計一個主要的驅動力。 例如，根據世界衛生組織 (WHO) 2021 年 10 月更新，全球約有 22 億人患有近視或遠視，其中約有 10 億人的視力障礙是可以預防的，或者尚未得到解決。 此外，據世界衛生組織稱，未經治療的老花眼估計影響全球約 8.26 億人。 根據上述數據，未矯正的屈光不正、白內障、年齡相關性黃斑變性和青光眼是全球視力損害和失明的主要原因，視力下降的發生與年齡無關。不過，據說大多數都超過了50歲。 因此，上述描述是被調查市場增長的動力，由於眼科超聲設備用於診斷此類眼科疾病，全球眼科疾病的負擔越來越重。表明

但是，其他診斷工具的進步和採用以及嚴格的政府法規預計會阻礙市場增長。

眼科超聲設備市場趨勢

B-Scan 佔有重要的市場份額

B 掃描或亮度掃描提供眼球的二維橫截面。 適用於閉合的眼瞼外側。 當眼睛檢查困難時，通常使用 B 掃描。 B 掃描因這些優勢而在全球範圍內廣泛使用，並且隨著公司開發新穎且技術先進的 B 掃描，需求也在增長。 疾病增多等因素加上市場參與者的舉措預計將推動市場增長。 例如，2022 年 2 月發表在國家醫學圖書館的一項研究表明，在過去 20 年中，眼部和附件疾病的住院率增加了 73.8%。 因此，高住院率增加了對診斷和外科眼科護理設備的需求，從而推動了市場的發展。 此外，上述調查報告顯示，視障人士多為年長者，年齡在50歲以上。 這個年齡段的人中有 80% 以上患有眼疾。 因此，預計老年人口負擔的增加將增加該國眼科疾病的患病率，從而推動該領域的增長。 糖尿病視網膜病變的流行是市場增長的主要驅動力之一。 根據美國眼科學會最近發布的流行病學統計數據，目前全球有 3.87 億糖尿病患者，預計到 2035 年這一數字將上升到 5.92 億。 此外，糖尿病性視網膜病變影響全世界 9300 萬人。 糖尿病視網膜病變在 1 型糖尿病患者中的患病率為 77.3%，在 2 型糖尿病患者中的患病率為 25.1%，其中 25% 至 30% 預計會發展為威脅視力的糖尿病性黃斑水腫。 5% 到 8% 的糖尿病視網膜病變患者需要激光治療。 多達 5% 的人可能需要玻璃體切除術。 眼底 B 型超聲檢查用於檢測和評估預測視力結果的糖尿病性視網膜病變並發症。

擴張等各種舉措是細分市場增長的重要因素。 2022 年 6 月，Lumivad Medical 通過在印度設立子公司擴大了其在印度的業務。 該公司提供多種眼科超聲產品，如 ABSOLU、COMPACT TOUCH 和 AXIALIS。 預計這些努力將擴大印度市場，從而推動整個全球市場的增長。

隨著各種眼病發病率的增加，預計未來幾年對B-Scan眼底超聲系統的需求將會增加。

北美主導市場，預計在預測期內將繼續保持這一勢頭

高可支配收入、高意識、老年人口增加和眼病流行等因素正在推動北美地區研究市場的增長。 各種已發表的研究文章提供了對失明和其他眼病流行率的見解。 例如，一篇引用克利夫蘭診所發表於 2022 年 1 月的文章指出，美國超過 340 萬年齡在 40 歲以上的人符合法定失明或視力矯正的定義。 尚未診斷的目標疾病的這種增加也有望推動市場增長。 同樣，安大略省驗光師協會2021年7月發表的一篇文章稱，隨著加拿大人口老齡化，矯正視力的人數將會增加，影響加拿大的醫療保健系統和經濟。 根據該報告，有 120 萬加拿大人患有視力喪失，僅安大略省就有 466,000 人。 上述消息來源還指出，超過 800 萬加拿大人，近 310 萬在安大略省，患有四大眼科疾病之一（年齡相關性黃斑變性、青光眼、糖尿病性視網膜病變、白內障）和視力喪失。它還提到生活在存在風險的狀態 眼科疾病的這種增加預計將增加對用於早期診斷的眼科超聲設備的需求並推動市場增長。

眼科超聲市場競爭對手分析

眼科超聲系統市場適度細分。 世界領先的公司製造了大部分眼科超聲系統。 擁有更多研究資金和更好的分銷系統的市場領導者正在市場中站穩腳跟。 市場上的主要參與者是 Appasamy Associates、DGH Technology Inc.、Micro Medical Devices、NIDEK、Optos PLC（Nikon Corporation）、Quantel Medical（Ellex Medical Lasers Ltd）、Lumibird Medical（Quantel Medical）、AMETEK（Reichert Inc）和 Sonomed Escalon。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 眼病患病率增加
    • 新眼科技術的出現
    • 政府公共衛生意識計劃的增加
  • 市場製約因素
    • 其他診斷工具的進步和採用率的提高
    • 嚴格的政府法規
  • 波特的五力分析
    • 供應商的議價能力
    • 買家和消費者的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品分類
    • A掃描
    • B超掃描
    • 組合掃描
    • 測厚儀
    • 超聲生物顯微鏡 (UBM)
  • 按方式
    • 便攜式
    • 獨立的
  • 最終用戶
    • 醫院
    • 眼科診所
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • AMETEK（Reichert Inc.）
    • Appasamy Associates
    • Carl Zeiss Meditec AG
    • Clarion Medical Technologies
    • DGH Technology Inc.
    • Halma plc
    • Lumibird Medical（Quantel Medical）
    • MEDA Co., Ltd（Tianjin Pharmaceutical Holdings Ltd）
    • Micro Medical Devices
    • NIDEK CO., LTD.
    • Optos PLC（Nikon Corporation）
    • Sonomed Escalon

第7章 市場機會與今後動向

簡介目錄
Product Code: 64423

The ophthalmic Ultrasound Systems Market is poised to grow at a CAGR of 7% during the forecast period.

The pandemic had an effect on the market and various research studies provide insight into that. For instance, according to a research study published by Parul C Gupta et. al., in the December 2021 edition of the Indian Journal of Ophthalmology, the studied clinic was expected to perform 7,500 cataract procedures, but due to the pandemic, they were able to perform only 2,500 procedures. This data suggests a significant decrease in cataract procedures during the COVID-19 pandemic. However, with the increase in screen time owing to long working hours, ocular problems are one of the most reported problems worldwide and this may lead to an increase in the prevalence of optical disorders and boost the growth of the studied market during the studied period. For instance, as per a research study published in November 2021 by Jason M. Nagata et al., the average screen time of adolescents in the United States increased to 7.7 hours per day from 3.8 hours per day in pre-pandemic time and as per the same source, increase in screen time has a negative effect on the physical and mental state of the adolescent. Hence, the long-term impact of COVID-19 is expected to have a positive impact on the studied market.

The increasing burden of optical disorders such as myopia (nearsightedness), hyperopia (far-sightedness), astigmatism (distorted vision), and presbyopia, among others around the world are expected to be the major driving factor for the growth of the ophthalmic ultrasound systems market during the forecast period of the study. For instance, according to the October 2021 update of the World Health Organization (WHO), approximately 2.2 billion people around the world have near or distance vision impairment and about 1 billion of these cases of vision impairment could be prevented or are yet to be addressed. Further, as per WHO, unaddressed presbyopia is estimated to affect about 826 million people around the world. Also, as per the above-mentioned source, uncorrected refractive errors, cataracts, age-related macular degeneration, and glaucoma among others, are the major cause of vision impairment and blindness globally, and vision loss can affect people of any age but the majority is over the age of 50 years. Hence, the statements mentioned above indicate that there is a growing burden of eye diseases across the globe which is a fuelling factor for the growth of the market studied as ophthalmic ultrasound devices are used in the diagnosis of such eye diseases.

However, the increasing advancement and adoption of other diagnostic tools and rigorous government regulations are expected to hinder market growth.

Ophthalmic Ultrasound Systems Market Trends

B-Scan to Hold a Significant Share of the Market

B-Scan or Brightness Scan provides a two-dimensional cross-sectional view of the eye. It is applied on the exterior of the shut eyelid. B-scan is utilized when examining the eye ordinarily is challenging. With such advantages of a B-Scan, it is widely used globally, and companies are coming up with novel and technologically advanced B-scans, which are fuelling demand for the same. Factors such as increasing diseases coupled with the initiative by market players are expected to increase the market growth. For instance, a study published in the National Library of Medicine in February 2022 stated that the hospital admission rate for diseases of the eye and adnexa increased by 73.8% in the last two decades. Thus, high hospital admission rates increase the demand for diagnostic and surgical eye care devices, boosting the market. The above-mentioned study also reported that most people with visual impairment are elderly and fall into the age group of 50 years and above. More than 80% of people in this age group suffer from eye diseases. Therefore, the growing burden of the geriatric population is expected to increase the prevalence of eye diseases in the country and drive segmental growth. The prevalence of diabetic retinopathy is one of the key factors in market growth. The American Academy of Ophthalmology recently revealed epidemiological statistics showing that 387 million people worldwide currently suffer from diabetes mellitus, with that number expected to rise to 592 million by 2035. Worldwide, diabetic retinopathy affects 93 million individuals. Type 1 diabetes patients have a 77.3% prevalence of diabetic retinopathy, whereas type 2 diabetes patients have a 25.1% prevalence, with 25% to 30% of those patients predicted to develop vision-threatening diabetic macular edema. 5% to 8% of diabetic retinopathy patients require laser therapy. Up to 5% of individuals might need a vitrectomy operation. Ophthalmic B-mode ultrasound is used for the detection and evaluation of diabetic retinopathy complications that predict the visual outcome.

Various initiatives, such as expansion are key factors in segmental growth. In June 2022, Lumibird Medical expanded its presence in India by creating a new subsidiary in the country. The company offered various ophthalmic ultrasound products such as ABSOLU, COMPACT TOUCH, AXIALIS, etc. With such initiatives, the market is expected to grow in the country thus boosting the overall segmental growth globally.

This growing incidence rate of various eye diseases is anticipated to boost demand for B-Scan ocular ultrasound devices in the coming years.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

Factors such as high disposable incomes, high awareness, the rising geriatric population, and the prevalence of eye diseases are fueling the growth of the market studied in the North American region. Various research articles published provide insight into the prevalence of blindness and other eye disorders. For instance, the article sourced in Cleveland clinic articles published in January 2022, mentioned that more than 3.4 million people in the United State aged 40 and above meet the definition of legal blindness or have corrected vision. Such increasing target disorders, which are yet to be diagnosed are also expected to drive the growth of the market. Similarly, the article published in the Ontario Association of optometrists in July 2021 mentioned that as Canada's population ages, the number of individuals living with corrected vision is growing and will impact Canada's healthcare system and economy. The report shows that 1.2 million Canadians live with the loss of vision, 466,000 in Ontario alone. The above-mentioned source also mentioned that over 8 million Canadians, nearly 3.1 million in Ontario, are living with one of the four major eye diseases (age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts) and have or are at risk of vision loss. Such increasing prevalence of eye diseases is expected to rise the demand for ophthalmic ultrasound systems for early diagnosis and drive the growth of the market.

Ophthalmic Ultrasound Systems Market Competitor Analysis

The Ophthalmic Ultrasound Systems Market is moderately fragmented. The global key players are manufacturing the majority of ophthalmic ultrasounds. Market leaders with more funds for research and a better distribution system have established their position in the market. The major players operating in the market are Appasamy Associates, DGH Technology Inc., Micro Medical Devices, NIDEK CO., LTD., Optos PLC (Nikon Corporation), Quantel Medical (Ellex Medical Lasers Ltd), Lumibird Medical (Quantel Medical), AMETEK (Reichert Inc.), and Sonomed Escalon.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Eye Diseases
    • 4.2.2 Advent of Novel Ophthalmic Technologies
    • 4.2.3 Rise in Public Health Awareness Programs by Government
  • 4.3 Market Restraints
    • 4.3.1 Increasing Advancement and Adoption of Other Diagnostic Tools
    • 4.3.2 Rigorous Government Regulations
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 A- Scan
    • 5.1.2 B- Scan
    • 5.1.3 Combined Scan
    • 5.1.4 Pachymeter
    • 5.1.5 Ultrasound Bio-microscopy (UBM)
  • 5.2 By Modality
    • 5.2.1 Portable
    • 5.2.2 Standalone
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ophthalmology Clinics
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 COMPANY PROFILES
    • 6.1.1 AMETEK (Reichert Inc.)
    • 6.1.2 Appasamy Associates
    • 6.1.3 Carl Zeiss Meditec AG
    • 6.1.4 Clarion Medical Technologies
    • 6.1.5 DGH Technology Inc.
    • 6.1.6 Halma plc
    • 6.1.7 Lumibird Medical (Quantel Medical)
    • 6.1.8 MEDA Co., Ltd (Tianjin Pharmaceutical Holdings Ltd)
    • 6.1.9 Micro Medical Devices
    • 6.1.10 NIDEK CO., LTD.
    • 6.1.11 Optos PLC (Nikon Corporation)
    • 6.1.12 Sonomed Escalon

7 MARKET OPPORTUNITIES AND FUTURE TRENDS